Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Follicular lymphoma: in vitro effects of combining lymphokine-activated killer (LAK) cell-induced cytotoxicity and rituximab- and obinutuzumab-dependent cellular cytotoxicity (ADCC) activity.
García-Muñoz R, López-Díaz-de-Cerio A, Feliu J, Panizo A, Giraldo P, Rodríguez-Calvillo M, Grande C, Pena E, Olave M, Panizo C, Inogés S. García-Muñoz R, et al. Among authors: panizo c, panizo a. Immunol Res. 2016 Apr;64(2):548-57. doi: 10.1007/s12026-015-8747-9. Immunol Res. 2016. PMID: 26659089
Imatinib inhibits proliferation of Ewing tumor cells mediated by the stem cell factor/KIT receptor pathway, and sensitizes cells to vincristine and doxorubicin-induced apoptosis.
González I, Andreu EJ, Panizo A, Inogés S, Fontalba A, Fernández-Luna JL, Gaboli M, Sierrasesúmaga L, Martín-Algarra S, Pardo J, Prósper F, de Alava E. González I, et al. Among authors: panizo a. Clin Cancer Res. 2004 Jan 15;10(2):751-61. doi: 10.1158/1078-0432.ccr-0778-03. Clin Cancer Res. 2004. PMID: 14760098 Free article.
First-line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders: retrospective, single-centre study.
Martínez-Calle N, Alfonso A, Rifón J, Herrero I, Errasti P, Rábago G, Merino J, Panizo Á, Pardo J, Prósper F, García-Muñoz R, Lecumberri R, Panizo C. Martínez-Calle N, et al. Among authors: panizo c, panizo a. Eur J Haematol. 2017 Jan;98(1):38-43. doi: 10.1111/ejh.12782. Epub 2016 Jun 28. Eur J Haematol. 2017. PMID: 27232286
Maintenance therapy with ex vivo expanded lymphokine-activated killer cells and rituximab in patients with follicular lymphoma is safe and may delay disease progression.
López-Díaz de Cerio A, García-Muñoz R, Pena E, Panizo Á, Feliu J, Giraldo P, Rodríguez-Calvillo M, Martínez-Calle N, Grande C, Olave MT, Andrade-Campos M, Bandrés E, Núñez-Córdoba JM, Inogés S, Panizo C. López-Díaz de Cerio A, et al. Among authors: panizo c, panizo a. Br J Haematol. 2020 Jun;189(6):1064-1073. doi: 10.1111/bjh.16474. Epub 2020 Mar 4. Br J Haematol. 2020. PMID: 32130737 Free article. Clinical Trial.
Large cell carcinoma of the lung: an endangered species?
Pardo J, Martinez-Peñuela AM, Sola JJ, Panizo A, Gúrpide A, Martinez-Peñuela JM, Lozano MD. Pardo J, et al. Among authors: panizo a. Appl Immunohistochem Mol Morphol. 2009 Oct;17(5):383-92. doi: 10.1097/PAI.0b013e31819bfd59. Appl Immunohistochem Mol Morphol. 2009. PMID: 19444077
[Role of surgery in the treatment of primary gastric lymphoma].
Baixauli J, Hernandez-Lizoain JL, Panizo A, Espí A, Rotellar F, Rodríguez-Spiteri N, Olea JM, Martínez Regueira F, Díez-Caballero A, Pardo F, Cienfuegos JA. Baixauli J, et al. Among authors: panizo a. Rev Med Univ Navarra. 2000 Oct-Dec;44(4):21-8. Rev Med Univ Navarra. 2000. PMID: 11341053 Spanish.
[Pathological anatomy of organ transplantation].
Pardo FJ, Joly M, Idoate M, Sola I, de Alava E, Panizo A. Pardo FJ, et al. Among authors: panizo a. Rev Med Univ Navarra. 1994 Oct-Dec;38(4):189-94. Rev Med Univ Navarra. 1994. PMID: 8992597 Review. Spanish.
80 results